P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01. (23rd June 2022)

• Record Type: Journal Article
• Authors: Bobin, A.; Manier, S.; De Keizer, J.; Karlin, L.; Perrot, A.; Hulin, C.; Caillot, D.; Mariette, C.; Lenain, P.; Richez, V.; Tiab, M.; Touzeau, C.; Jaccard, A.; Decaux, O.; Araujo, C.; Belhadj, K.; Benboubker, L.; Déal, C.; Macro, M.; Vincent, L.; Arnulf, B.; Bareau, B.; Braun, T.; Calmettes, C.; mamoun, D.; Zerazhi, H.; Demarquette, H.; Feugier, P.; Fohrer-sonntag, C.; Godet, S.; Petillon, M.-O.; Avet-Loiseau, H.; Leleu, X.;
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 783
• Page End: 784
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000846440.48761.8d
• Languages: English
• ISSNs: 2572-9241